TEVA-SACUBITRIL / VALSARTAN DIN 02571080
Status: Approved
Holder: TEVA CANADA LIMITED
Health Canada record
| Active ingredient(s) | SACUBITRIL (SACUBITRIL VALSARTAN SODIUM HYDRATE COMPLEX) 49 MG; VALSARTAN (SACUBITRIL VALSARTAN SODIUM HYDRATE COMPLEX) 51 MG |
|---|---|
| Dosage form | Tablet |
| Route | Oral |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | C09DX04 VALSARTAN AND SACUBITRIL |
| Original market date | |
| Current status date | 27-Aug-2026 |
| Source | Health Canada DPD |
Establishment licence of the holder
Teva Canada Limited — licence 101810, currently licensed, last inspection rating C (2025-03-04).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing SACUBITRIL (SACUBITRIL VALSARTAN SODIUM HYDRATE COMPLEX)
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02446928 | ENTRESTO | NOVARTIS PHARMACEUTICALS CANADA INC | Tablet | SACUBITRIL (SACUBITRIL VALSARTAN SODIUM HYDRATE COMPLEX) 24 MG; VALSARTAN (SACUBITRIL VALSARTAN SODIUM HYDRATE COMPLEX) 26 MG | Marketed |
| 02446936 | ENTRESTO | NOVARTIS PHARMACEUTICALS CANADA INC | Tablet | SACUBITRIL (SACUBITRIL VALSARTAN SODIUM HYDRATE COMPLEX) 49 MG; VALSARTAN (SACUBITRIL VALSARTAN SODIUM HYDRATE COMPLEX) 51 MG | Marketed |
| 02446944 | ENTRESTO | NOVARTIS PHARMACEUTICALS CANADA INC | Tablet | SACUBITRIL (SACUBITRIL VALSARTAN SODIUM HYDRATE COMPLEX) 97 MG; VALSARTAN (SACUBITRIL VALSARTAN SODIUM HYDRATE COMPLEX) 103 MG | Marketed |
| 02549018 | SANDOZ SACUBITRIL-VALSARTAN | SANDOZ CANADA INCORPORATED | Tablet | SACUBITRIL (SACUBITRIL VALSARTAN SODIUM HYDRATE COMPLEX) 24 MG; VALSARTAN (SACUBITRIL VALSARTAN SODIUM HYDRATE COMPLEX) 26 MG | Marketed |
| 02549026 | SANDOZ SACUBITRIL-VALSARTAN | SANDOZ CANADA INCORPORATED | Tablet | SACUBITRIL (SACUBITRIL VALSARTAN SODIUM HYDRATE COMPLEX) 49 MG; VALSARTAN (SACUBITRIL VALSARTAN SODIUM HYDRATE COMPLEX) 51 MG | Marketed |
| 02549034 | SANDOZ SACUBITRIL-VALSARTAN | SANDOZ CANADA INCORPORATED | Tablet | SACUBITRIL (SACUBITRIL VALSARTAN SODIUM HYDRATE COMPLEX) 97 MG; VALSARTAN (SACUBITRIL VALSARTAN SODIUM HYDRATE COMPLEX) 103 MG | Marketed |
| 02571072 | TEVA-SACUBITRIL / VALSARTAN | TEVA CANADA LIMITED | Tablet | SACUBITRIL (SACUBITRIL VALSARTAN SODIUM HYDRATE COMPLEX) 24 MG; VALSARTAN (SACUBITRIL VALSARTAN SODIUM HYDRATE COMPLEX) 26 MG | Approved |
| 02571099 | TEVA-SACUBITRIL / VALSARTAN | TEVA CANADA LIMITED | Tablet | SACUBITRIL (SACUBITRIL VALSARTAN SODIUM HYDRATE COMPLEX) 97 MG; VALSARTAN (SACUBITRIL VALSARTAN SODIUM HYDRATE COMPLEX) 103 MG | Approved |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 38195 | 2026-08-27 | Abbreviated New Drug Submission (ANDS) |